The 2018 farm bill legalized hemp products that offer a high similar to marijuana nationwide. Experts worry that lax regulations present a public health risk.
Articles on DEA
Displaying all articles
Washington looked the other way as coup leaders and drugs cartels conspired to turn Honduras into a center of the cocaine trade.
U.S. Congress might not pursue full cannabis legalization this year. But it should still provide Americans with some of Canada’s legal clarity.
Kratom, which has been linked to many deaths in the US, has been grown in Southeast Asia for centuries. There, people drink a tea made from the herb, with no ill effects. Why the difference?
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
The herb kratom has a large following and is so popular that it is sold in vending machines. The FDA recently issued a public warning about the herb, which contains low levels of opioids.
The trend toward marijuana legalization is growing, but the legality, or illegality, of cannabis at the federal level hasn’t changed at all.
Bolivia is the first cocaine-producing country to take a harm reduction approach to tackling the drug trade.
Complaints about the ban of kratom, often used by recovering opiate addicts, have been vociferous, but not always backed by facts.
147m people used the drug last year. We need to know much more about it.
Top contributors
-
Research Officer, London School of Economics and Political Science
-
Leverhulme Early Career Research Fellow, UCL Institute of the Americas, UCL
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Executive Director, Cannabis Law & Policy Project, University of Washington
-
Professor of Law, Indiana University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor in Criminology, Loughborough University
-
Professor of Operations Research, Brock University
-
Assistant Professor, Management Area, McIntire School of Commerce,, University of Virginia
-
Professor of Medicinal Chemistry, University of Florida College of Pharmacy, University of Florida
-
Outgoing Interim Director of the Frederick S. Pardee Center for the Study of the Longer-Range Future, Boston University
-
Fellow in Drug Policy, Rice University